Drug Screening

Drug Screening is a systematic process within pharmaceutical research that identifies and evaluates bioactive compounds for therapeutic potential by assessing their biological effects on cellular or tissue-level models, particularly through in vitro platforms such as organ-on-chip systems derived from pluripotent stem cells.

3.1K

Publications

203.7K

Citations

17.1K

Authors

3.3K

Institutions

Publications per year

2017–2026

1.4K

Authors

17.1K

  1. AK
    Ali Khademhosseini

    Harvard University, United States

    11 publications · 2.2K citations

    11

    h-index

  2. HC
    Hans Clevers

    Hubrecht Institute for Developmental Biology and Stem Cell Research, Netherlands

    10 publications · 1.8K citations

    10

    h-index

  3. KE
    Kevin E. Healy

    University of California, Berkeley, United States

    10 publications · 970 citations

    10

    h-index

  4. JC
    Joseph C. Wu

    Stanford University, United States

    9 publications · 1.4K citations

    9

    h-index

  5. HY
    Hanry Yu

    National University of Singapore, Singapore

    8 publications · 647 citations

    8

    h-index

1–5 of 17.1K

Venues

  1. Proceedings of the National Academy of Sciences

    PNAS · 263 publications · 28.8K citations

    87

    h-index

  2. Scientific Reports

    114 publications · 6.8K citations

    46

    h-index

  3. Analytical Chemistry

    86 publications · 3.9K citations

    39

    h-index

  4. Lab on a Chip

    48 publications · 4.8K citations

    34

    h-index

  5. PLoS ONE

    61 publications · 4.3K citations

    33

    h-index

1–5